Comparison of the effect of ropivacaine 2% combined with triamcinolone and ropivacaine 2% in ilioinguinal nerve block in controlling acute pain after herniorrhaphy and return to activity time

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20241012063337N1

Enrollment

Registered

2024-11-24

Start date

2024-10-22

Completion date

Unknown

Last updated

2025-01-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Inguinal hernia. Inguinal hernia

Interventions

Intervention 1: Intervention group: Intervention group: After surgery, in addition to 7.5 cc of ropivacaine 2%, this group also receives 1 cc of triamcinolone 40 mg. Intervention 2: Control group: Thi

Eligibility

Sex/Gender

All

Age

25 Years to 65 Years

Inclusion criteria

Inclusion criteria: age between 25 to 65 In terms of inguinal hernia, the patients are in A.S.A class (1 and 2) and undergo herniorrhaphy surgery under spinal anesthesia.

Exclusion criteria

Exclusion criteria: Having an allergy to the studied drugs Recurrent hernias Hernia surgeries with general anesthesia History of surgical incision in the hernia area History of uncontrolled diabetes History of renal failure History of cirrhosis Pregnant women Patients with high intracranial pressure if reported by the patient Patients with psychiatric diseases and seizures

Design outcomes

Primary

Measure	Time frame
Pain. Timepoint: 4 , 8, 12 and 24 hours after surgery. Method of measurement: Using the Visual Analogue Scale (VAS).;Ability of walking. Timepoint: 4 , 8, 12 and 24 hours after surgery. Method of measurement: Patient statement.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactParia Bodduhi

Karaj University of Medical Sciences

paria.bodduhi@gmail.com+98 912 586 9688

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026